TIMEKIA HILL: Open Payments
NPI 1326542887 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 79 payments from 9 companies in 2025. Trend: 2023 $743 · 2024 $955 · 2025 $1,484
Food & beverage: $1,457Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $327 |
| Teva Pharmaceuticals USA, Inc. | 14 | $311 |
| Alkermes, Inc. | 13 | $304 |
| ABBVIE INC. | 17 | $225 |
| Janssen Pharmaceuticals, Inc | 8 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: COBENFY, ARISTADA, VRAYLAR, UZEDY, INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, HETLIOZ.
Industry payments across SC — which companies pay providers there.
